Board of Directors
“Carry on doing what you believe will enhance the care for people in need”. –Dr. Sushilan Vasoo, Director
The Executive Committee of the Board of Directors; from left: Managing Director, Company Secretary, Executive Chairman and Deputy Chairman
Prof. Wischik is board certified in psychiatry and Professor of Old Age Psychiatry at the University of Aberdeen, Scotland. A pioneer in Tau research, Prof. Wischik's work on Tau pathology began in 1985 in the laboratory of Sir Martin Roth, who was the first to correlate tangles with Alzheimer's dementia, and later with Sir Aaron Klug (Nobel Laureate) at Cambridge University. Prof. Wischik subsequently discovered the Tau protein compositional structure of the Alzheimer tangles and established that it was possible to dissolve tangles with pharmaceutically viable compounds that act as Tau Aggregation Inhibitors. He also demonstrated a direct link between clinical dementia and Tau aggregation at the biochemical level, irrespective of ß-amyloid load in human brain. As TauRx Chairman, Prof. Wischik has led the company to its present stage, has developed its portfolio of projects to the phase 3 clinical level and has worked with his Singaporean colleagues to raise ~$150m to date.
Deputy Chairman – Tay Siew Choon
Mr Tay was the COO of Singapore Technologies Pte Ltd., a multi-billion technology and industrial corporation, before he retired in 2004. Mr Tay has many years of experience in managing diverse technology businesses and, in addition to his position as Deputy Chairman of the TauRx board, he is also a board member at WisTa Laboratories Ltd (a TauRx group company), Pan United Corporation Ltd and Straco Corporation Ltd. He holds a degree in electrical engineering and an MSc in systems engineering.
Managing Director – Dr. Seng Shay Way, MD
Dr Seng is a practising obstetrician, gynaecologist and reproductive specialist at Gleneagles Hospital, Singapore. Dr Seng received his medical degree from the Royal College of Surgeons in Ireland and obtained his Masters of reproductive medicine from the University of New South Wales in Australia. He is a member of the Royal College of Obstetricians and Gynaecologists, London and a fellow of the Academy of Medicine, Singapore. He is currently the Medical director of KM Seng’s OG Practice Pte Ltd and a visiting IVF specialist at Raffles Hospital. He is also a board member of Age D'Or Healthcare Pte Ltd and a board member of the welfare committee of the Sree Narayana home for the aged sick and the Meranti home in Pelangi village.
Director and Chairman of the Scientific Advisory Committee – Prof. Stephen Logan
Prof. Stephen Logan was appointed to be the first Professor of Neuroscience at the University of Aberdeen in 1994, subsequently becoming Dean of the Medical School, Vice-Principal and, since August 2004, Senior Vice-Principal of the University of Aberdeen. Professor Logan has held posts as Medical Research Council Fellow, Senior Lecturer and Professor of Neuroscience at the University of Birmingham. He is currently a member of the Chief Scientist's Advisory Committee (Health Department), a member of the Steering Group of the Translational Medicine Research Collaboration, a Board Member of ACSEF (formally known as Scottish Enterprise Grampian), and a board member of WisTa Laboratories Ltd. and PoreDeen Pte Ltd (TauRx group companies). Professor Logan is a neurophysiologist whose research interests are in the way the brain controls blood pressure, memory and appetite. He has published more than 100 scientific articles and has served on Research Council, Wellcome Trust and Health Department Advisory Panels. He has key interests in strategic issues around creating and maintaining a world-class research base and the requirements for exploitation of intellectual property for wealth creation.
Director – Dr. Sushilan Vasoo
Dr. Vasoo is an Associate Professorial Fellow in the Department of Social Work, National University of Singapore and an independent director of AEI Corporation. He is also currently a board member of WisTa Laboratories Ltd and PoreDeen Pte Ltd. (TauRx group companies) and has been a Justice of Peace in Singapore since 2005. He was a Member of Parliament in the Government of Singapore from 1984 to 2001 and also served as Chairman of the Government Parliamentary Committee for Community Development. Dr. Vasoo graduated from the University of Hong Kong with a PhD and Masters in Social Work and holds a Diploma in Social Studies with distinction from the University of Singapore. His research areas cover social issues in ageing.
Director – George Chia
Mr Chia has been running his own paper business for 42 years. He is also a board member of WisTa Laboratories Ltd. and PoreDeen Pte. Ltd. (TauRx Group companies), and is the Chairman of Premier Disposable Products Ltd (Hong Kong) and Guangdong Josco Disposable Product Ltd (China). Prior to his present appointment, Mr Chia was Managing Director of Kookaburra Paper Products Pte. Ltd and Premier Paper Doyleys Pte. Ltd.
Director – Toby O’Connor
Mr. O’Connor is Chief Executive Officer of The Islamic Bank of Asia (IB Asia) where he is concentrating on the development of IB Asia’s Merchant Banking platform in Asia and the Middle East covering Direct Investment, Advisory services, Treasury and Capital Markets activities. IB Asia is a subsidiary of DBS Bank, a leading financial services group active in Asia and originally created as the Development Bank of Singapore. Prior to joining IB Asia, Mr. O'Connor was a Managing Director at JP Morgan Chase & Co. where he spent a 19-year career in a number of Investment Banking product and client coverage roles in Mergers and Acquisitions, Capital Markets, Financial Sponsor Private Equity and Sovereign Wealth Fund areas based in New York, Latin America, London and the Middle East. Prior to joining J.P. Morgan in 1992, Mr. O’Connor served in the Irish Guards. Mr. O’Connor is a graduate of DartmouthCollege, in the United States, and the Royal Military Academy Sandhurst, in the UK.
Director – Tan Sri Lim Kok Thay
Tan Sri Lim Kok Thay is the the Chairman and Chief Executive of Genting Berhad, the holding company of the Genting Group. He holds a Bachelor of Science degree in Civil Engineering from the University of London, UK and attended the Programme Management Development of Harvard Business School, Harvard University, USA in 1979. He is also the Chairman and Chief Executive of Genting Malaysia Berhad, the Chief Executive and a Director of Genting Plantations Berhad, the Executive Chairman of Genting Singapore, RWSPL and GENUK and has served in various positions with the Genting Group since 1976.
He is Chairman of the Board of Trustees of The Community Chest, Malaysia. He also sits on the boards of trustees of several other charitable organizations in Malaysia. He is a Visiting Professor of the Institute of Biomedical Engineering, Imperial College, London, UK, appointed since October 2009 and an Honorary Professor of Xiamen University, China since December 2007.
Director – Tan Kong Han
Mr Tan Kong Han is the President and Chief Operating Officer of Genting Berhad and Deputy Chief Executive of Genting Plantations Berhad. He has more than 13 years working experience in investment banking prior to joining Tanjong Public Limited Company as the Group Chief Operating Officer in 2003. He left Tanjong Public Limited Company in 2007 to join Genting. He holds a MA from St. John’s College, Cambridge and was called to the English Bar (Lincoln’s Inn) in 1989 and the Malaysian Bar in 1990.
Alternate Director to Prof. Claude Wischik – Marcus Wichik
Mr. Wischik trained as a solicitor at Shepherd & Wedderburn LLP, and has worked at the International Criminal Tribunal for the Former Yugoslavia, for the Scottish Government Legal Directorate. At TauRx, his responsibilities include the review and negotiation of contracts, oversight of the company’s Compassionate Use programme, providing administrative support to the DSMB and development of the company’s Human Resource policies as well as involvement in many other projects that benefit from his legal and medical training. He is a practicing Scottish solicitor and notary public and holds bachelor’s degrees in both law and medical science & law from the University of Aberdeen, and a Master of Law degree from the University of Edinburgh.
Alternate Director to Tay Siew Choon – Goh Chung Meng
Mr. Goh is a Director of AVI-TECH Electronics Ltd and ACE Investment Management Pte Ltd. Prior to his present appointment, Mr. Goh held senior positions in Deloitte & Touche Management Consultants, Carr Indosuez Asia (an investment bank) and Suez Asia Holdings (an Asian private equity fund). From 2001 to 2008, Mr. Goh served as a Panel Member of a Singapore government innovation and research fund, The Enterprise Challenge Unit (TEC), PS 21 Office, Public Service Division, Prime Minister's Office. Mr Goh graduated from the NUS Business School, National University of Singapore with a Bachelor of Business Administration (BBA).
Alternate Director to Dr. Seng Shay Way – Dr. Loh Yin Sze
Dr. Loh is a medical doctor who did her clinical rotations in Singapore and has also trained in molecular biology basic research. In 2004 Dr. Loh was awarded the NUS-NUH Annual Meeting "Young Doctor Award" for her research work in the field of discovery of novel therapeutics for use in prostate cancer. Dr. Loh has also worked as a Financial Research Analyst covering the healthcare, biomedical and pharmaceutical sectors when she was employed at Phillip Securities Pte. Ltd. She graduated from the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery.
Alternate Director to Prof. Stephen Logan – Frederick Stevenson-Robb
Mr. Stevenson-Robb is the Director of Research and Innovation at the University of Aberdeen where he is responsible for Research Funding, Commercialisation and University Intellectual Property. Mr Stevenson-Robb is also a Director of Aberdeen University Research and Industrial Services, New Era Exploration Ltd and WisTa Laboratories Ltd. (a TauRx group company). He was also co-founder of Auvation Ltd., a drug discovery and development company. Mr Stevenson-Robb graduated from the University of Aberdeen with a Master’s degree (Hons) in Psychology. He also holds a Post-Graduate Diploma in Personnel and Business Administration from the Robert Gordon University. Mr Stevenson-Robb has supported the creation and development of more than twenty University start-up companies across a wide range of technology fields.
Alternate Director to Toby O’Connor – Joan Tan
Joan Tan is a Senior Vice President with Islamic Bank of Asia (IB Asia) Direct Investment team based in Singapore. IB Asia is a subsidiary of DBS Bank, a leading financial services group active in Asia and originally created as the Development Bank of Singapore. Prior to Joan’s transfer to IB Asia in July 2012, she was with DBS Bank Private Equity team monitoring its investment portfolio for 6 years. Joan has also spent another 6 years with DBS Bank Wholesale Banking Business Unit Controlling, covering capital markets. Before that, she was with Standard Chartered Bank Business Finance and KPMG Audit. Joan graduated with a Bachelor of Commerce (Accounting) degree from MurdochUniversity in Western Australia and is an associate member of CPA Australia.
Alternate Director to Tan Sri Lim Kok Thay – Goh Lee Sian
Ms Goh Lee Sian is the Senior Vice President – Legal of Genting Berhad. She was previously the in-house legal counsel of Maxis Communications Berhad. She holds a Bachelor of Economics and Bachelor of Laws from Monash University in Australia and a Masters in Business Administration from University of Central Florida, USA. She was called to the Malaysian Bar in 1987.
Alternate Director to Tan Kong Han – Woon Yoke Sun
Ms Woon Yoke Sun is Senior Vice President – Strategic Investment of Genting Berhad. She has been in the investment banking business for nearly 18 years where she specializes in equity research. She holds a Masters in Economics from University of Malaya in Malaysia.
Board Observer – Prof. Franz Theuring
Professor Theuring is a consultant to the State of Berlin in Biotechnology, to the European Union in Molecular Medicine and to the pharmaceutical industry. He is an elected Member of the Berlin Scientific Society (BWG) where he currently acts as a Vice President. Besides his role in TauRx, he is co-founder of the Proteome Factory, a biotech company based in Berlin and focussing on proteomic services. Professor Theuring graduated in biology from the Universities of Brauschweig and Goettingen. He subsequently earned a PhD from the University of Gottingen in 1986, and worked as a post-doctoral research fellow at the Max Planck Institute for Biophysical Chemistry. Professor Theuring established transgenic technologies at the Max Planck Institute and later at the ICMB of Schering AG, Berlin. He received his Habilitation from the Free University of Berlin in Molecular Biology and Biochemistry in 1996, and after 8 years at Schering AG, was appointed in 1996 to a Professorship in Molecular Pharmacology at the Charité - University Medicine Berlin.